Vercise Genus™ Deep Brain Stimulation (DBS) System

Tailor a DBS system specific to your workflow and each of your patients’ needs. With five MR-Conditional* implantable pulse generators (IPGs), the most therapy options and Image Guided Programming, Vercise Genus™ Deep Brain Stimulation System enables you to personalize DBS therapy as unique as each one of your patients.

Configure or select a product to continue to order

DBS therapy without compromise.

Easily customize therapy to match each patient’s needs with the Vercise Genus DBS system.

How it works

Choose from five small, contoured rechargeable and non-rechargeable MR-Conditional* Implantable Pulse Generators (IPGs) designed for patient comfort and convenience, with the most therapy options†.

Featuring Boston Scientific’s next innovation in Image Guided Programming, Vercise™ Neural Navigator 5 allows you to see stimulation to personalize DBS therapy in each patient’s specific anatomy.

Vercise Genus IPGs leads remote tablet vn5 software

See DBS from every angle with Vercise™ Neural Navigator 5

No two DBS patients are alike. 

Vercise Neural Navigator 5 makes it easier and more efficient to ​personalize your patient’s DBS journey.​


Why choose the Vercise Genus DBS System

Unmatched precision, flexibility, and control.

With more than 250,000 patients implanted worldwide and 10 years of proven performance1, Boston Scientific has a DBS battery you can depend on.

Vercise Genus IPGs P8, P16, P32, R16 and R32.

DBS batteries designed for patient comfort and convenience

Rechargeable options provide 30 days of stimulation between recharging cycles2. Non-rechargeable options include the Vercise™ P8 Battery—the only directional single channel primary cell in the market. 

68% of patients see an improvement in systems or reduction in side effects by switching to a Boston scientific DBS device (n=22)3.


Discover the Vercise Genus DBS system

Vercise Neural Navigator 5

Boston Scientific's next innovation in Image Guided Programming.

Semi-bipolar stimulation and anodic stimulation capabilities are only available with Boston Scientific and are demonstrated to increase side effect threshold4,5 and improve efficacy.6

Vercise Genus DBS System suite of IPGs

Choose from five small, contoured batteries designed for patient comfort and convenience.

ImageReady™ MR Conditional, rechargeable and non-rechargeable options

Vercise™ Cartesia™ Directional Lead

Precisely shape and steer stimulation where it’s needed most and leverage more programming flexibility by combining the power of Multiple Independent Current Control (MICC) with the Vercise Cartesia Directional Lead.

Subscribe for updates

Receive emails about the latest DBS advances, clinical data and product news.


References:

MRI conditional symbol.

The Vercise Genus™ DBS System, Vercise Genus Mixed System with Vercise™ M8 Adapter, Vercise Genus Mixed System with Vercise™ Adapter S8, Vercise Gevia™ DBS System, and Vercise™ DBS Lead-only system (before Stimulator is implanted) provide safe access to full-body MRI scans when used with specific components and the patient is exposed to the MRI environment under specific conditions defined in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems.

*MRI conditional when all conditions of use are met.

†Information for competitive devices excerpted from the literature published by Medtronic (M982261A015 Rev A, M939241A051 Rev A, M013074C001 Rev B, M982097A013 Rev A, M13075C001 Rev B, M019192C002 Rev A) and Abbott (ARTEN600150429 - B, ARTEN600102238 - A, ARTEN600266398 -A, ARTEN600308953 -A, ARTEN600308947 -A), and
Schüpbach, Michael & Chabardes, Stephan & Matthies, Cordula & Pollo, Claudio & Steigerwald, Frank & Timmermann, Lars & Vandewalle, Veerle & Volkmann, Jens & Schuurman, P.. (2017). Directional leads for deep brain stimulation: Opportunities and challenges. Movement Disorders. 32. 10.1002/mds.27096.
Steffen, J. K., Reker, P., Mennicken, F. K., Dembek, T. A., Dafsari, H. S., Fink, G. R., Visser-Vandewalle, V., & Barbe, M. T. (2020). Bipolar Directional Deep Brain Stimulation in Essential and Parkinsonian Tremor. Neuromodulation: Technology at the Neural Interface, 23(4), 543–549. DOI: 10.1111/ner.13109
Reker, P., Dembek, T. A., Becker, J., Visser-Vandewalle, V., & Timmermann, L. (2016). Directional deep brain stimulation: A case of avoiding dysarthria with bipolar directional current steering. Parkinsonism & Related Disorders, 31, 156-158. https://doi.org/10.1016/j.parkreldis.2016.08.007 
Kirsch, A. D., Hassin-Baer, S., Matthies, C., Volkmann, J., & Steigerwald, F. (2018). Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism & Related Disorders, 55, 61-67. https://doi.org/10.1016/j.parkreldis.2018.05.015.

Results from different clinical investigations are not directly comparable. Information provided for educational purposes only. 

  1. Boston Scientific data on file.  
  2. Yu X, et al. (2013). Characterizing rechargeable IPG charge cycle time in DBS. North American Neuromodulation Society (NANS) 2013.   
  3. Ojukwu DI, Wang AR, Hornbeck TS, Lim EA, Sharrard J, Dhall R, Buch VP, Halpern CH. Conversion to Hybrid Deep Brain Stimulation System to Enable Multi-Contact Fractionation Can be Therapeutic. Mov Disord. 2022 Apr 7. doi: 10.1002/mds.29007. Epub ahead of print. PMID: 35393689.  
  4. Steffen, J. K., Reker, P., Mennicken, F. K., Dembek, T. A., Dafsari, H. S., Fink, G. R., Visser-Vandewalle, V., & Barbe, M. T. (2020). Bipolar Directional Deep Brain Stimulation in Essential and Parkinsonian Tremor. Neuromodulation: Technology at the Neural Interface, 23(4), 543–549. DOI: 10.1111/ner.13109  
  5. Reker, P., Dembek, T. A., Becker, J., Visser-Vandewalle, V., & Timmermann, L. (2016). Directional deep brain stimulation: A case of avoiding dysarthria with bipolar directional current steering. Parkinsonism & Related Disorders, 31, 156-158. https://doi.org/10.1016/j.parkreldis.2016.08.007  
  6. Kirsch, A. D., Hassin-Baer, S., Matthies, C., Volkmann, J., & Steigerwald, F. (2018). Anodic versus cathodic neurostimulation of the subthalamic nucleus: A randomized-controlled study of acute clinical effects. Parkinsonism & Related Disorders, 55, 61-67. https://doi.org/10.1016/j.parkreldis.2018.05.015